Dr. Michael Wang, MD
Claim this profileMD Anderson Cancer Center
Studies Von Willebrand Disease
Studies Mantle Cell Lymphoma
8 reported clinical trials
14 drugs studied
Area of expertise
1Von Willebrand Disease
2Mantle Cell Lymphoma
CCND1 positive
t(11;14)(q13;q32) positive
CD20 positive
Affiliated Hospitals
Clinical Trials Michael Wang, MD is currently running
PRV Combination Therapy
for Mantle Cell Lymphoma
Primary Objectives: To estimate the percent of participants who achieve a best response of complete response by the end of the PRV combination therapy in the induction therapy phase in patients with previously untreated MCL.
Recruiting1 award Phase 25 criteria
rVWF +/− ADVATE
for Von Willebrand Disease
The main aim of the study is to check effectiveness, side effects, and tolerability of vonicog alfa (recombinant von Willebrand factor \[rVWF\]), with or without ADVATE, in the treatment and control of nonsurgical bleeding events in pediatric participants (less than (\<)18 years of age) with severe hereditary von Willebrand disease (VWD). The participants will be treated with vonicog alfa for 12-18 months. Their von Willebrand Disease will be treated by their doctor according to their doctor's usual clinical practice. During the study, participants will be followed up at clinics or over telephone calls.
Recruiting2 awards Phase 3
More about Michael Wang, MD
Clinical Trial Related1 year of experience running clinical trials · Led 8 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Michael Wang, MD has experience with
- Pirtobrutinib
- Rituximab
- Venetoclax
- JCAR017 (lisocabtagene Maraleucel) 2-dose Schedule
- JCAR017 (lisocabtagene Maraleucel) Single-dose Schedule
- Antihemophilic Factor (Recombinant)
Breakdown of trials Michael Wang, MD has run
Von Willebrand Disease
Mantle Cell Lymphoma
Mixed-Cell Lymphoma
Diffuse Large B-Cell Lymphoma
Follicular Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Michael Wang, MD specialize in?
Michael Wang, MD focuses on Von Willebrand Disease and Mantle Cell Lymphoma. In particular, much of their work with Von Willebrand Disease has involved treating patients, or patients who are undergoing treatment.
Is Michael Wang, MD currently recruiting for clinical trials?
Yes, Michael Wang, MD is currently recruiting for 2 clinical trials in Houston Texas. If you're interested in participating, you should apply.
Are there any treatments that Michael Wang, MD has studied deeply?
Yes, Michael Wang, MD has studied treatments such as Pirtobrutinib, Rituximab, Venetoclax.
What is the best way to schedule an appointment with Michael Wang, MD?
Apply for one of the trials that Michael Wang, MD is conducting.
What is the office address of Michael Wang, MD?
The office of Michael Wang, MD is located at: MD Anderson Cancer Center, Houston, Texas 77030 United States. This is the address for their practice at the MD Anderson Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.